China Cord Blood Corporation Earnings & Price Target Update

China Cord Blood Corporation (NYSE:CO) is getting prepared to post earnings results on 6/21/2017 4:30:00 PM. For the last period, the company reported quarter over quarter EPS growth of 10.80% and quarter over quarter sales growth of 18.60%.

Heading into the earnings release, covering sell-side analysts have a consensus target price of $6.50 on China Cord Blood Corporation shares. After a recent check, company stock has been trading near the $8.78 mark.

Sell-side analysts have also provided a consensus recommendation of 3.00 on company shares. Investors will be eagerly watching to see if the firm beats or misses on the earnings front.

Depending on the earnings numbers reported, China Cord Blood Corporation (NYSE:CO) stock may see increased volatility following the report. In terms of recent volatility, the average for the month is 6.87% and 7.13% for the past week. The relative volume (ratio between current volume and 3-month average) is presently sitting at 0.40.

Since the start of the New Year, China Cord Blood Corporation (NYSE:CO) shares have seen a move of 43.95%. Looking back over the last month, shares have performed 14.86%. For the past 5 days of trading, the stock has seen a move of 5.64%.

Let’s also take a brief look at the stock price in relation to some highs/lows and moving averages. China Cord Blood Corporation (NYSE:CO) shares have been recently spotted -5.08% away from the 52-week high, and 105.62% away from the 52-week low mark.

After a recent look, shares have been seen 45.08% from the 200-day moving average, and 12.36% from the 50-day moving average. The stock’s current RSI reading is at 59.88.

As the earnings date approaches, we can see that insider ownership is currently 49.60% shares, and institutional ownership is at 17.70% for China Cord Blood Corporation (NYSE:CO) stock. Over the past few months, insider ownership has seen a move of 0.00% while institutional ownership has changed 3.78%.